<DOC>
	<DOCNO>NCT00192491</DOCNO>
	<brief_summary>- To compare immune response measles , mumps , rubella , varicella antigen follow vaccination child receive FluMist concurrently MMRIIÒ VARIVAXÒ child receive intranasal placebo mist concurrently MMRIIÒ VARIVAXÒ ( Group 2 vs. Group 1 ) . - To compare immune response three strain influenza ( H1N1 , H3N2 , B ) follow two dose regimen FluMist child receive initial FluMist dose concurrently MMRIIÒ VARIVAXÒ child receive two dos FluMist alone ( Group 2 vs. Group 3 ) .Secondary : - To assess safety tolerability concurrent administration FluMist MMRIIÒ VARIVAXÒ .</brief_summary>
	<brief_title>Trial Assess Safety , Tolerability , Immunogenicity Influenza Virus Vaccine , Trivalent , Types A &amp; B , Live Cold-Adapted ( FluMist ) Measles , Mumps , Rubella , Varicella Vaccines Administered Concurrently Healthy Children</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>12 15 month age ( reach 16th month birthday ) ; In good health ; Parent/guardian available telephone home visit ; Ability parent/guardian understand comply requirement protocol ; Signed informed consent parent/guardian ; Up date primary series recommend vaccine per standard clinic practice local vaccine availability . Previous known measles , mumps , rubella varicella disease ; Previous vaccination measles , mumps , rubella varicella disease ; Hypersensitivity egg egg protein ; Signs symptom immunosuppressive immune deficiency disease ongoing immunosuppressive therapy ; immunosuppressed individual living household ; Acute febrile ( &gt; 100.0oF [ 37.8°C ] oral ) illness clinically significant upper respiratory illness within 72 hour prior enrollment ; Use aspirin ( acetylsalicylic acid ) aspirincontaining product month prior enrollment , expect use aspirin enrol study ; Administration intranasal medication within two week prior enrollment expect receipt study ; Administration live virus vaccine within one month prior enrollment 30 day Visit 3 ; Administration inactivate vaccine within two week prior enrollment 30 day Visit 3 ; Participation another investigational trial within one month prior enrollment expect enrollment another investigational trial study ; Receipt blood product within three month prior vaccination expect receipt within study duration ; Any condition , opinion investigator , would interfere interpretation evaluation vaccine . History two episode medically attend wheeze illness parent/guardian report . History medically attend wheeze illness bronchodilator medication use within four week enrollment parent/guardian report .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>15 Months</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>